The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Pseudohypoparathyroidism Type Ia/Ib

Genetic disorders of PTH-receptor signaling causing target-organ resistance to parathyroid hormone.

Written by: Saygı Hospital Health Guide Editorial Board
Published:

This content is for general information; please consult your physician for diagnosis and treatment.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Endokrinoloji department. Book Appointment →

What is Pseudohypoparathyroidism Type Ia/Ib?

Pseudohypoparathyroidism type Ia (PHP-Ia) results from heterozygous loss-of-function mutations on the maternal GNAS allele, reducing Gs-alpha activity. Patients show resistance to PTH, TSH, gonadotropins, and GHRH, plus the somatic features of Albright hereditary osteodystrophy (AHO).

Pseudohypoparathyroidism type Ib (PHP-Ib) is caused by epigenetic defects (loss of methylation) at the GNAS locus restricted to renal expression, producing isolated PTH resistance without AHO features.

Diagnosis combines characteristic biochemistry (low calcium, high phosphate, elevated PTH, normal 25-OH vitamin D) with confirmatory GNAS sequencing and methylation analysis.

Symptoms

PHP-Ia: short stature, round face, brachydactyly (especially short 4th–5th metacarpals), subcutaneous ossifications, obesity, intellectual disability
Hypocalcemia: paresthesia, muscle cramps, tetany, Chvostek/Trousseau signs, seizures
Hyperphosphatemia and basal ganglia calcifications (chronic)
PHP-Ia additional resistance: hypothyroidism, hypogonadism, growth hormone deficiency
PHP-Ib: hypocalcemic symptoms only, normal stature and appearance

Risk Factors

Maternal inheritance of GNAS mutation (PHP-Ia)
Imprinting defects at GNAS locus (PHP-Ib, sporadic or familial)
Family history of AHO or unexplained hypocalcemia
Consanguinity (autosomal recessive familial PHP-Ib variants)

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Recurrent hypocalcemic symptoms with elevated PTH and high phosphate
  • Childhood with short metacarpals, round face, and short stature
  • Family member diagnosed with AHO or PHP
  • Tetany or seizures triggered by hypocalcemia

Treatment Methods

01
Calcium supplementation (1000–2000 mg elemental/day)
02
Active vitamin D analog (calcitriol 0.25–1 μg/day, titrated to normal-low calcium)
03
Avoid hypercalciuria — monitor 24-hour urinary calcium and renal ultrasound
04
Treat associated hormone resistances (levothyroxine for hypothyroidism, sex hormone replacement for hypogonadism)
05
Phosphate-restricted diet, possible phosphate binders if hyperphosphatemia persists
06
Genetic counseling and family screening (parent-of-origin matters)
07
Multidisciplinary follow-up: endocrinology, genetics, orthopedics for AHO

Which Department to Visit?

You can visit our Endokrinoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Endokrinoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.